• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 17th December 2021

OHE Thanks Trustees for Their Service

As a Charity, OHE is governed by a Board of Trustees which today is comprised of a mixture of academic and industry experts. OHE has been privileged to have many leading health economists serving on its Boards and Committees over…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

As a Charity, OHE is governed by a Board of Trustees which today is comprised of a mixture of academic and industry experts. OHE has been privileged to have many leading health economists serving on its Boards and Committees over the nearly 60 years of its existence.

Two giants in the academic field are stepping down from the OHE Board of Trustees at the end of 2021, Professor Mike Drummond and Professor Bengt Jonnson, after more than a decade of service.

Both have contributed a combination of management acumen – having run their respective university departments and consulting businesses – and of research oversight as leading thinkers and contributors in the field. Notably, both have been awarded the prestigious Avedis Donabedian Award in recognition of lifetime achievement in the area of improving health outcomes.

Mike Drummond took over from Professor Tony Culyer as Chair of the OHE Policy Committee in 2011, became Chair of the Management Committee in 2014 and most recently became Chair of Trustees when OHE became a charity (a not-for-profit) in 2016. Mike is Professor of Health Economics at the University of York and was Director of the Centre for Health Economics for ten years. He is the author of two major textbooks on health economics and more than 700 scientific papers. He has been President of both the International Society of Technology Assessment in Health Care (now HTAi), and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). He is currently Co-Editor-in-Chief of Value in Health. In 2010, he was made a member of the Institute of Medicine of the National Academies in the USA, and he received the John Eisenberg Award, in 2012 in recognition of exemplary leadership in the practical application of medical decision-making research.

Bengt joined the OHE Policy Committee in 2007 and became a Trustee of OHE, like Mike, in 2016. Bengt is, like Mike, one of the true pioneers in the field – his 1976 doctoral thesis was on cost-benefit analysis in public health and medical care. He has since published hundreds of papers, reports, and book chapters worldwide. In 1979, Bengt founded the Swedish Institute for Health Economics (IHE), using the OHE as a model, and in 1982 became Professor of Health Economics at the University of Linköping, where he founded the Center for Medical Technology (CMT). IHE and CMT today are the focal institutions for health economics in Sweden. In 1991, Bengt moved to the Stockholm School of Economics, where is now Professor Emeritus and remains active, as ever.

OHE has been fortunate to have benefited from their support and wisdom over more than a decade and we are grateful for their service. Both Mike and Bengt intend to spend less time working, but anybody who knows them will be sceptical.

OHE is also saying goodbye to Louise Timlin who joined the Board in 2019. Lou is Senior Director in Global Patient Outcomes and Real-World Evidence at Eli Lily & Co. where she has had a distinguished 22-year career in a variety of Health Economics and Outcomes Research roles. Lou brought great management insight with a long track record of managing large teams, as well as deep strategic and technical insight in many of the topics in Health Economics and Outcomes Research and Health Technology Assessment in which OHE is highly active. Much of OHE’s work is global in nature, and Lou brought a wealth of experience in multi-country and global health economic issues. Lou is both passionate and knowledgeable about equality, diversity and inclusion and provided sound advice and challenge around these and many other topics. Her activity within ISPOR’s Women in HEOR was incredibly important and influential and resonated significantly with the OHE team. 

During a talk on the importance of role models for women and girls at ISPOR Barcelona, Lou shared a quote from Marian Wright Edelman “You can’t be what you can’t see.” Our team is 63% female and representation on both the executive and management levels of the organisation is 66%. Her activism has been an inspiration, and we hope that OHE can play a role in supporting a fairer and more equal community.

We wish Lou well in her next adventure and thank her for her service to OHE and to the wider health economics community.

OHE will be announcing our new Trustees in January as well as a new Chair.

 

 

Related News

Group 11119
  • News
  • February 2023

Applications open for MSc Fellowship Programme 2023

Read more
Prize event
  • News
  • January 2023

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

Read more
  • News
  • July 2022

OHE is Leading Research to Develop an EQ-5D ‘Bolt-on’ for Hearing

Read more
MicrosoftTeams-image-6_0
  • News
  • June 2022

OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!